Catch up on today’s top five analyst upgrades with this list compiled by The Fly: 1. Sage Therapeutics (SAGE) upgraded to Buy from Neutral at Mizuho with analyst Vamil Divan seeing an attractive risk/reward following the company’s collaboration deal with Biogen (BIIB). 2. Oshkosh (OSK) upgraded to Overweight from Sector Weight at KeyBanc with analyst Steve Barger saying he thinks Oshkosh is one of the higher-quality ways to play a machinery recovery and that as industrial and construction activity re-accelerates, thinks it will benefit from improving sales in its Access Equipment segment. 3. Funko (FNKO) upgraded to Overweight from Neutral at Piper Sandler with analyst Erinn Murphy saying shares are down 51% year-to-date but the company is on track to execute Q4 at least inline with expectations. 4. Michaels (MIK) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Simeon Gutman saying while he still sees the core business facing challenges sustaining sales growth and profitability when the consumer spending backdrop normalizes, he is “being more open-minded” on the potential that Michaels may be able to hold onto some of the outsized demand it has seen over the last couple of quarters. 5. Allegheny Technologies (ATI) upgraded to Buy from Hold at Benchmark with analyst Josh Sullivan saying the planned exit from the commodity stainless sheet products business will alter Allegheny’s historical risk profile by removing its most volatile vertical, while also concentrating its portfolio into high value markets. This list is just a portion of The Fly’s full analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)
previous post
next post